Abstract:Objective: To investigate the effects and related mechanism of estrogen receptor β (ERβ) agonist on the migration and oxidative stress of human umbilial vein endothelial cells (HUVECs) under high glucose condition. Methods: The experimental research method was adopted. HUVECs were routinely cultured and passaged, and then cells of the logarithmic growth phase were collected for the subsequent experiments. The cells were divided into three groups according to the random number table, including normal control group (cultured with Roswell Park Memorial Institute 1640 cell culture medium (the same cell culture medium below) containing 5.5 mmol/L D-glucose), high glucose alone group (cultured with cell culture medium containing 25.0 mmol/L D-glucose alone), and high glucose+ERβ agonist diarylpropionitrile (DPN) group (cultured with cell culture medium containing 25.0 mmol/L D-glucose and 10 μmol/L DPN). Scratch test was conducted to detect the cell migration rate in the 3 groups at 24 h post scratching. Fluorescent probe method was used to detect the reactive oxygen species (ROS, denoted by red fluorescence intensity) of cells in the 3 groups on 5 d post culture. Western blotting was used to detect the protein expression levels of vascular endothelial growth factor (VEGF) and superoxide dismutase 2 (SOD2) of cells in the 3 groups on 5 d post culture. In the above-mentioned experiments, cells were grouped and cultured correspondingly as before, the number of samples in each group was 5. Data were statistically analyzed with one-way analysis of variance and least significant difference t test. Results: At 24 h post scratching, the cell migration rate in high glucose alone group was (36±5)%, which was significantly lower than (76±4)% of normal control group and (65±5)% of high glucose+DPN group (t=14.511, 9.603, P<0.01), and the cell migration rate in high glucose+DPN group was significantly lower than that in normal control group (t=3.943, P<0.01). On 5 d post culture, the level of ROS of cells in high glucose alone group (1.81±0.12) was significantly increased compared with normal control group and high glucose+DPN group (1.00±0.14, 0.91±0.15, t=9.679, 10.549, P<0.01), while the level of ROS of cells in normal control group and high glucose+DPN group were close (t=1.031, P>0.05). On 5 d post culture, the protein expression levels of VEGF and SOD2 of cells in high glucose alone group were significantly lower than the levels of normal control group (t=14.175, 13.787, P<0.01) and high glucose+DPN group (t=6.321, 17.750, P<0.01). The protein expression level of VEGF of cells in high glucose+DPN group was significantly lower than the level of normal control group (t=7.206, P<0.05), while the protein expression level of SOD2 of cells in high glucose+DPN group was significantly higher than the level of normal control group (t=2.890, P<0.05). Conclusions: The activation of ERβ can improve the inhibition of HUVECs migration induced by high glucose and alleviate oxidative stress injury induced by high glucose, which may be achieved by promoting the expression of VEGF and SOD2.

PARTIALY INHIBITION OF THE EFFECTS OF ESTRODIOL ON RETINAL ENDOTHELIAL CELL BY NGF SIGNALING BLOCKAGE

17Β-Estradiol Protects the Retinal Nerve Cells Suppressing TLR2 Mediated Immune-Inflammation and Apoptosis from Oxidative Stress Insult Independent of PI3K

17Β-Estradiol Impedes Bax-involved Mitochondrial Apoptosis of Retinal Nerve Cells Induced by Oxidative Damage Via the Phosphatidylinositol 3-Kinase/akt Signal Pathway.

Involvement of Insulin/Phosphoinositide 3-Kinase/Akt Signal Pathway in 17β-Estradiol-mediated Neuroprotection

G-Protein-Coupled Receptor 30 Mediates Rapid Neuroprotective Effects of Estrogen Via Depression of NR2B-Containing NMDA Receptors

PI3K/Akt and NF-κB activation following intravitreal administration of 17β-estradiol: neuroprotection of the rat retina from light-induced apoptosis.

17SS-Estradiol Antagonizes the Down-Regulation of ERα/NOS-3 Signaling in Vascular Endothelial Dysfunction of Female Diabetic Rats.

[Effects of Long-Term Replacement Therapy of Compound Nylestriol Tablet or Low-Dose 17 Beta-Estradiol on the Expression of Nerve Growth Factor in OVX Rat Hippocampal Formation].

17Β-Estradiol Up-Regulates Nrf2 Via PI3K/AKT and Estrogen Receptor Signaling Pathways to Suppress Light-Induced Degeneration in Rat Retina

Effect of GnRH II and GnRH I on secretion of VEGF by eutopic and ectopic endometrial stromal cells of endometriosis patients

Effects of Estradiol on EAAs Release by Deltamethrin in Glial Cell

Protective effect of ethyl ferulate against hypoxic injury in retinal cells and retinal neovascularization in an oxygen-induced retinopathy model

Estrogen Regulates Excitatory Amino Acid Carrier 1 (EAAC1) Expression Through Sphingosine Kinase 1 (sphk1) Transacting FGFR-mediated ERK Signaling in Rat C6 Astroglial Cells

[Effects and Mechanism of Estrogen Receptor Β Agonist on the Migration and Oxidative Stress of Human Umbilical Vein Endothelial Cell under High Glucose Condition].

Neuronal-Driven Angiogenesis: Role of NGF in Retinal Neovascularization in an Oxygen-Induced Retinopathy Model

Effects of estradiol valerate and remifemin on norepinephrine signaling in the brain of ovariectomized rats.

Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.

EFFECT OF 17-Β ESTRADIOL ON NITRIC OXIDE SYNTHASE GENE EXPRESSION OF HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS IN PRIMARY CULTURE

Estrogen, via ESR2 receptor, prevents oxidative stress-induced Müller cell death and stimulates FGF2 production independently of NRF2, attenuating retinal degeneration

Effect of estrogen on vascular endothelial growth factor expression in rat osteoblasts

Inhibitory Effect of Vascular Endothelial Growth Factor Sirna on Retinal Neovascularization in Mouse